Thomas H Lee Partners LP (THL) to Buy inVentiv Health for $1.1 Bln

May 7, 2010 |

1 min read

BANGALORE, May 6 (Reuters) - Pharmaceutical services provider InVentiv Health Inc (VTIV.O) said it agreed to be acquired by private equity firm Thomas H. Lee Partners [THL.UL] for about $1.1 billion.

Mergers & acquisitions

Syneos Health

MORE ON THIS TOPIC

Handshake in retro collage style. Hands with halftone effect make a deal, a hand comes out of a laptop, online deals. Vector modern illustration.

Immunology and inflammation

Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026

January 29, 2026

·

2 min read

·

Tristan Manalac

Insights

Biotech’s New Cycle, JPM Deal Hype and Where Alpha Still Hides

January 29, 2026

·

1 min read

·

Jennifer Smith-Parker

A contemporary art collage depicting a giant ear listening to a message bubble while covering it with a hand. The concept of taking in a useful experience or overhearing a new idea.

Gene editing

Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless

January 28, 2026

·

2 min read

·

Tristan Manalac

Pictured: Boehringer Ingelheim's office in California

Inflammatory bowel disease

Boehringer Commits up to $1.26B in IBD Pact With China’s Simcere

January 27, 2026

·

2 min read

·

Tristan Manalac